BiondVax Pharmaceuticals Alpha and Beta Analysis
| BVXVDelisted Stock | USD 1.35 0.03 2.17% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BiondVax Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in BiondVax Pharmaceuticals over a specified time horizon. Remember, high BiondVax Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BiondVax Pharmaceuticals' market risk premium analysis include:
Beta (0.13) | Alpha (0.64) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BiondVax |
BiondVax Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BiondVax Pharmaceuticals market risk premium is the additional return an investor will receive from holding BiondVax Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BiondVax Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BiondVax Pharmaceuticals' performance over market.| α | -0.64 | β | -0.13 |
BiondVax Pharmaceuticals Fundamentals Vs Peers
Comparing BiondVax Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BiondVax Pharmaceuticals' direct or indirect competition across all of the common fundamentals between BiondVax Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as BiondVax Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BiondVax Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing BiondVax Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BiondVax Pharmaceuticals to competition |
| Fundamentals | BiondVax Pharmaceuticals | Peer Average |
| Return On Equity | -56.02 | -0.31 |
| Return On Asset | -0.31 | -0.14 |
| Current Valuation | 21.94 M | 16.62 B |
| Shares Outstanding | 3.65 M | 571.82 M |
| Shares Owned By Insiders | 20.01 % | 10.09 % |
| Shares Owned By Institutions | 10.69 % | 39.21 % |
| Number Of Shares Shorted | 4.88 K | 4.71 M |
BiondVax Pharmaceuticals Opportunities
BiondVax Pharmaceuticals Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Healthcare Stocks Moving Up and Down Wednesday ENVB, ZURA, KMDA, RETA, BHG, CWBR, PTCT, ELEV - InvestorsObserver | 05/24/2023 |
2 | StockNews.com Initiates Coverage on BiondVax Pharmaceuticals | 05/31/2023 |
3 | BiondVax Pharmaceuticals Receives New Coverage from Analysts at StockNews.com | 06/08/2023 |
4 | Short Interest in BiondVax Pharmaceuticals Ltd. Declines By 80.9 | 07/14/2023 |
About BiondVax Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BiondVax or other delisted stocks. Alpha measures the amount that position in BiondVax Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
BiondVax Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of BiondVax Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BiondVax Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of BiondVax Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of BiondVax Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of BiondVax Pharmaceuticals' management manipulating its earnings.
| 29th of November 2023 Upcoming Quarterly Report | View | |
| 15th of April 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 15th of April 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with BiondVax Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |